A look at the pharma giant's earnings forecast for the year ahead, with Jean-Pierre Garnier, GlaxoSmithKline CEO and CNBC's Mike Huckman

14

Shares of British drug giant GlaxoSmithKline could suffer their worst one-day percentage drop in eight years, reports CNBCs Mike Huckman

A look at the days earnings and over-the-counter news from GlaxoSmithKline, with Mike Huckman, CNBC Pharmaceuticals Reporter

...GlaxoSmithKline ...earnings reported today. A U.S. Food and Drug Administration committee meets on July 30 to review Avandia's safety after researchers said on May 21 that the diabetes pill may ...

...GlaxoSmithKline ...earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris Pharmaceuticals Inc. Net income fell to 1.31 billion pounds ($2.61 billion), or 24....